Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

China flag China · Delayed Price · Currency is CNY
19.19
+0.64 (3.45%)
Sep 5, 2025, 3:04 PM CST
3.45%
Market Cap21.43B
Revenue (ttm)2.84B
Net Income (ttm)73.85M
Shares Out1.12B
EPS (ttm)0.06
PE Ratio290.24
Forward PE174.45
Dividend0.09 (0.47%)
Ex-Dividend DateJun 6, 2025
Volume25,435,386
Average Volume33,223,974
Open18.90
Previous Close18.55
Day's Range18.29 - 19.56
52-Week Range12.93 - 23.45
Beta0.95
RSI56.07
Earnings DateAug 29, 2025

About SHE:300601

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. Its marketed vaccines include SARS-COV-2 vaccines, HIB conjugate vaccines, 13-valent pneumococcal conjugate vaccines, recombinant hepatitis B vaccines, 23-valent pneumococcal polysaccharide vaccines, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccines, cell-free whitebait b-type haemophilus influenzae combined vaccines, and measles and rubella combined vaccines. The company’... [Read more]

Sector Healthcare
Founded 1992
Employees 1,913
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300601
Full Company Profile

Financial Performance

In 2024, SHE:300601's revenue was 2.65 billion, a decrease of -23.75% compared to the previous year's 3.48 billion. Earnings were 201.65 million, a decrease of -76.59%.

Financial Statements

News

There is no news available yet.